National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

nolatrexed dihydrochloride
The dihydrochloride salt of nolatrexed, a water-soluble lipophilic quinazoline folate analog with antineoplastic activity. Nolatrexed occupies the folate binding site of thymidylate synthase, resulting in inhibition of thymidylate synthase activity and thymine nucleotide synthesis with subsequent inhibition of DNA replication, DNA damage, S-phase cell cycle arrest, and caspase-dependent apoptosis. This agent also exhibits radiosensitizing activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Nolatrexed
nolatrexed hydrochloride
US brand name:Thymitaq
Code name:AG337
Chemical structure name:3,4-dihydro-2-amino-6-methyl-4-oxy-5-(4-pyridylthio)-quinazoline Dihydrochloride



Previous:nitric oxide-releasing acetylsalicylic acid derivative, nitroglycerin, Nizoral, NM-3, NMPRTase inhibitor APO866
Next:Nolvadex, nordihydroguaiaretic acid, norethindrone acetate, norgestrel, Norlutate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov